FTC Staff Comment to Attorney General of Texas Concerning Certified Registered Nurse Anesthetists (CRNA) Regulations
Matter Number:
V200010
Advocacy Filings
When government bodies and other organizations consider cases or policy decisions that affect consumers or competition, the FTC may offer insight and expertise to decision makers by filing an advocacy letter. To find a specific filing, use the filters on this page.
Displaying 20 results
Displaying 1 - 20 of 815
Pages
FTC Staff Comment to Texas Health and Human Services Commission Regarding Certificate of Public Advantage Applications
Matter Number:
201 0090
201 0119
FTC Staff Letter to the Centers for Medicare and Medicaid Services Regarding the Interim Final Rule with Policy and Regulatory Revisions in Response to the COVID-19 Public Health Emergency
Matter Number:
V200009
Joint Comment of the FTC Staff and DOJ Antitrust Division Staff to the California State Assembly Concerning California Assembly Bill 1541
Matter Number:
V200008
Comment by FTC and DOJ staff in response to invitation from California Assembly Member Jim Wood concerning the likely competitive effects of A.B.1541, a proposal to further restrict contracting between beer manufacturers and beer wholesalers.
FTC Staff Letter to Department of Health and Human Services Concerning the 21st Century Cures Act: Interoperability, Information Blocking and the ONC Health IT Certification Program Rule
Matter Number:
V190002
FTC Staff Comment to the Ohio House of Representatives Concerning Ohio House Bill 177
Matter Number:
V200005
Comment by FTC staff concerning Ohio House Bill 177, a proposal to expand the scope of practice of Advanced Practice Registered Nurses (APRNs) in Ohio.
FTC Staff Comment to the Kansas House of Representatives Concerning Kansas House Bill 2412
Matter Number:
V200006
FTC staff comment concerning Kansas House Bill 2412, a proposal to expand the scope of practice for Advanced Practice Registered Nurses (APRNs) in Kansas.
Federal Trade Commission's Statement of Public Interest
Matter Number:
P859910
The Federal Trade Commission filed a statement of public interest in connection with the International Trade Commission's investigation of certain memory modules and the components thereof, ITC Investigation No. 337-TA-1089.
FTC Comment to Texas Medical Board on Its Proposed Rule 193.13 to Add Supervision Requirements for Texas-Certified Nurse Anesthetists
Matter Number:
V200009
FTC Staff Comment to the North Carolina State Board of Dental Examiners Regarding Proposed Rule Changes to 21 N.C. Admin. Code 16W
Matter Number:
V200003
Comment of the Staff of the Federal Trade Commission to Massachusetts Rep. Paul J. Donato regarding HB1869 and SB1329
Matter Number:
V2000002
Comment of the Staff of the Federal Trade Commission’s Bureau of Consumer Protection: Preliminary Draft for the NIST Privacy Framework
Matter Number:
P205400
Related Release:
Comment of the Staff of the Federal Trade Commission’s Bureau of Consumer Protection: In the Matter of Proposed Rule with Request for Public Comment, Debt Collection Practices (Regulation F)
Matter Number:
P064803
Docket Number:
CFPB–2019–0022; RIN 3170–AA41
Related Release:
Comment of the Federal Trade Commission to the Ad Hoc Committee on Rules and Procedures for the United States District Court for the Southern District of Florida
Matter Number:
P034101
FTC Staff Comment Before the Department of Health and Human Services Regarding the 21st Century Cures Act: Interoperability, Information Blocking, and the ONC Health IT Certification Program
Matter Number:
V190002
Docket Number:
RIN 0955-AA01
FTC Staff Comment to the FDA Department of Health and Human Services on Its Updated Guidance for Industry on the “Nonproprietary Naming of Biological Products”
Matter Number:
V190001
Docket Number:
FDA-2013-D-1543
Statement of the Federal Trade Commission to the Alaska Senate Committee on Health & Social Services on Certificate of Need Laws and SB 1
Matter Number:
V080007
Federal Trade Commission Comment On the Food and Drug Administration’s Revised Draft Guidance For Industry, Entitled “Citizen Petitions and Petitions For Stay of Action Subject To Section 505(q) of the Federal Food, Drug, and Cosmetic Act.”
Matter Number:
P013510
Docket Number:
FDA-2009-D-0008
FTC Staff Comment to the NTIA: Developing the Administration’s Approach to Consumer Privacy
Matter Number:
P195400
Docket Number:
18021780-8780-01
FTC staff submitted a comment to the NTIA regarding the development of the Administration’s approach to consumer privacy. The comment discusses the FTC’s balanced approach to privacy that weighs the risks of data misuse with the benefits of data to innovation and competition. The comment also offers observations on the timely topics of security, transparency, choice, and FTC enforcement. It concludes with a discussion of the future of privacy policymaking in the United States.
Related Release:
